Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/24/2022 | Press release | Distributed by Public on 01/24/2022 13:42
Please select the service you want to use:
Smartlinks | Hartford Financial Services Group Inc. | News | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Company Appointments | Corporate Officer Change | Financial Services | Insurance | Public Companies | Multiline Insurance and Brokers | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact